SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is generating massive investor interest as the market anticipates an upcoming earnings report, with community members heavily debating whether the company will announce a transformative partnership deal. The stock's recent price surge has led to a contentious tug-of-war between retail bulls anticipating a breakout and short sellers betting on a post-earnings pullback.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and community debate as investors weigh the company's recent earnings report against its long-term growth potential and aggressive short interest. While some shareholders are viewing price dips as a buying opportunity to capitalize on recent enterprise contract wins, others are expressing frustration over recurring sell-offs and the influence of short-sellers on the stock's immediate movement.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing intense community speculation as investors position themselves ahead of upcoming earnings, with many focusing on signs of improved unit economics and potential margin expansion under new leadership. The stock is trending as shareholders anticipate that favorable guidance could finally trigger a reversal of recent bearish sentiment and drive upward momentum.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is experiencing intense volatility as investors speculate on a potential short squeeze and a rumored partnership with OpenAI ahead of earnings. Community sentiment remains deeply polarized, with many traders frustrated by consistent intraday sell-offs while others aggressively defend their positions based on the CEO's recent large-scale share purchases.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave remains at the center of investor debate as the market weighs its massive $99.4 billion revenue backlog against concerns over mounting debt and widening quarterly losses. While some investors interpret the spending as necessary infrastructure buildout for an AI supercycle, others are heavily focused on the company's capital-intensive business model and a history of post-earnings volatility.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of investor attention as they prepare for a highly anticipated earnings report, with the community closely tracking the acquisition of Motiv Space Systems and progress on the Neutron launch vehicle. Shareholders are actively debating the company's long-term growth trajectory and vertical integration strategy, viewing these developments as key catalysts that could separate the stock from broader sector volatility.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is facing intense scrutiny as investors weigh upcoming earnings against a significant 14% workforce reduction aimed at optimizing operations for an AI-native strategy. The community remains deeply divided, with some betting on a rally driven by progress on the CLARITY Act and institutional adoption, while others are aggressively shorting the stock, citing poor historical performance and ongoing concerns over the company's cost structure.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing extreme volatility as investors weigh the company's aggressive capacity expansion against weak earnings and broader concerns about the sustainability of the AI infrastructure boom. The community remains deeply divided, with bulls pointing to robust demand for high-speed optical transceivers and recent government grants, while skeptics warn of a speculative bubble and poor fundamental performance.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors weigh potential impacts from the emerging prediction market sector and upcoming first-quarter earnings, leading to intense community debate over long-term growth prospects. Discussions are dominated by speculation on whether these new markets will cannibalize traditional sports betting revenue or serve as an additive growth driver for the platform.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is capturing significant attention as investors react to a record-breaking earnings report that highlighted strong revenue growth, increased guidance, and expanding engagements with hyperscalers. Community sentiment is overwhelmingly bullish, with many traders actively discussing the potential for a massive short squeeze and long-term upside as the company solidifies its critical role in LLM data engineering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Supernus Pharmaceuticals (SUPN) Beats Q1 Earnings and Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of +110.71% and +10.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages

Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) have been given a consensus rating of "Hold" by the nine ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and tw...

AMPH vs. RDY: Which Stock Should Value Investors Buy Now?

AMPH vs. RDY: Which Stock Is the Better Value Option?

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday

Amphastar Pharmaceuticals (NASDAQ:AMPH) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-amphastar-pharmaceuticals-inc-stock...

Boston Trust Walden Corp Reduces Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH

Boston Trust Walden Corp lessened its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,087,266 shares...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 7.4% - Time to Sell?

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 7.4% - Should You Sell...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Hold Rating from Jefferies Financial Group

Jefferies Financial Group restated a "hold" rating and set a $22.00 price objective on shares of Amphastar Pharmaceuticals in a research report on Tuesday...

Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives outlined growth drivers, competitive pressures, and pipeline priorities during a fireside chat at Needham & Company's 25th Annual Healthcare Conference. The discussion featured CFO Bill Peters, Senior VP of Corporate Communications Dan Dischner...

$AMPH Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.14 down -73.58% YoY
• Reported revenue of $171.17M up 0.38% YoY

Stocktwits

Amphastar Pharmaceuticals Inc

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.14 down -73.58% YoY
• Reported revenue of $171.17M up 0.38% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

https://files.quartr.com/streams/2026-05-07/6ba591c7-408e-4fa3-a965-563e2095f14b/1/live_transcript.jsonl?ref=U3RvY2t0d2l0cw==

AMPH  Earnings Call

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.71	--	--	N/A
Q4 '25	$0.92	$0.73	-20.89%	MISSED
Q3 '25	$0.83	$0.93	12.68%	BEAT
Q2 '25	$0.74	$0.85	14.61%	BEAT
Q1 '25	$0.69	$0.74	7.77%	BEAT

AMPH
Amphastar Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest AMPH News

AMPHAmphastar Pharmaceuticals Inc